Resolvin E1 Inhibits Corneal Allograft Rejection in High-Risk Corneal Transplantation
Author:
Affiliation:
1. Department of Ophthalmology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
2. Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China
Publisher
Association for Research in Vision and Ophthalmology (ARVO)
Subject
General Medicine
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phospholipase A2 as a modulator of infection, inflammation, and immunity;Phospholipases in Physiology and Pathology;2023
2. Targeting Angiogenesis via Resolution of Inflammation;Cold Spring Harbor Perspectives in Medicine;2022-07-11
3. Specialized pro-resolving mediators as modulators of immune responses;Seminars in Immunology;2022-01
4. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators;Frontiers in Immunology;2021-11-16
5. miR-151-5p alleviates corneal allograft rejection by activating PI3K/AKT signaling pathway and balancing Th17/Treg after corneal transplantation via targeting IL-2Rɑ;Annals of Translational Medicine;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3